NCT05807633View on ClinicalTrials.gov

Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

March 28, 2023

Study Completion Date

October 1, 2023

Conditions

Cesarean Section ComplicationsCesarean Section; Infection

Interventions

DEVICE

Novosyn®

Novosyn® for uterus closure in patients undergoing cesarian section

Trial Locations (1)

08243

Athaia Xarxa Assistencial Universitaria de Manresa, Manresa

Sponsors

Collaborators (1)

B.Braun Surgical SA

All Listed Sponsors

collaborator

B.Braun Surgical SA

INDUSTRY

lead

Aesculap AG

INDUSTRY